- This topic is empty.
-
Posts
-
Konica Minolta to Sell its Subsidiary Invicro LLC to Calyx Services Inc.
Konica Minolta, Inc. has announced a significant shift in its business strategy with the sale of its subsidiary Invicro, LLC to Calyx Services Inc. This move is part of a broader reevaluation of Konica Minolta’s involvement in the precision medicine sector.
Invicro, a company specializing in imaging analysis and medical imaging data analysis services, has been instrumental in supporting drug discovery. It was acquired by Konica Minolta to bolster its precision medicine initiatives through cutting-edge molecular digital imaging technologies, advanced analytics, and software solutions. However, with the need for continued investment to grow the business and considering Konica Minolta’s financial status, the decision was made to reclassify precision medicine as a ‘non-focused business’ in its Medium-term Business Plan for 2023-2025.
The sale to Calyx, a leading global provider of technology-enabled services for medical imaging and IRT/RTSM for drug developers and the clinical research community, is expected to close in the first quarter of the fiscal year ending March 31, 2025, subject to closing conditions and regulatory approvals.
This strategic divestment reflects Konica Minolta’s assessment of its business portfolio and the need to concentrate on areas where it can achieve the most significant impact. The transfer of Invicro to Calyx is anticipated to allow both entities to focus on their core strengths and continue to innovate in their respective fields.
- You must be logged in to reply to this topic.